| Patents for C08B 37 - Preparation of polysaccharides not provided for in groups; Derivatives thereof (24,467) |
|---|
| 02/06/2002 | EP1177216A1 Branched glucose soluble polymers and method for the production thereof |
| 02/06/2002 | EP0777487B1 Treatment of stroke associated with macrophage infiltration |
| 02/06/2002 | CN1078891C Amphiprotic fine porous particle and preparing method and use thereof |
| 02/05/2002 | US6344346 Polysaccharide, micro-organism and method for obtaining same, composition containing it and application |
| 02/05/2002 | CA2019481C Gellan gum sizing |
| 01/31/2002 | WO2002008441A1 Process for producing non-cellulosic callose fiber by plant protoplast and callose fiber |
| 01/31/2002 | WO2002008295A1 Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same |
| 01/31/2002 | US20020013408 Cross-linked polymer compositions and methods for their use |
| 01/31/2002 | US20020013292 Made by dissolving an amphiphilic heparin derivative comprising heparin conjugated to bile acids, sterols, or alkanoic acids in a water phase, dispersing the water phase in an organic phase to form an emulsion, drying the emulsion |
| 01/31/2002 | US20020013235 Comprises a cyclodextrin or a branched cyclodextrin and a vanillyl alcohol derivative, such as vanillyl-n butyl ether |
| 01/31/2002 | US20020012705 Polymer constructs |
| 01/31/2002 | DE10033059A1 New inclusion complexes of benzocaine in gamma-cyclodextrin, useful as non-volatile local anesthetics, e.g. for alleviating surface pain |
| 01/30/2002 | EP1176209A1 Production of Sphingomonas exopolysaccharides unattached to the surface of bacterial cells |
| 01/30/2002 | EP1176154A1 Carnosine derivatives, a process for the preparation thereof and pharmaceutical compositions containing them |
| 01/30/2002 | EP1176153A1 Sulfated fucogalactan |
| 01/30/2002 | EP1175500A1 Method for the selective esterification of polyoles |
| 01/30/2002 | EP1175226A1 Lipoglycan compositions and methods of treating parasitic infections |
| 01/30/2002 | EP1175157A1 Low molecular weight polymannuronate |
| 01/30/2002 | CN1078595C Water-soluble polysaccharide and a process for producing the same |
| 01/29/2002 | US6342592 Chiral compounds, their synthesis and use as a support |
| 01/29/2002 | US6342591 Amphipathic coating for modulating cellular adhesion composition and methods |
| 01/29/2002 | US6342486 Skin disorder treatment with glycans for antiinflammatory agents |
| 01/29/2002 | US6342367 Treatment of fish scales with enzyme for dissolving, adding water to form solutions and removal of polypeptides by-products |
| 01/29/2002 | US6342305 Colorants and colorant modifiers |
| 01/24/2002 | WO2002006373A1 Hydrogel films and methods of making and using therefor |
| 01/24/2002 | WO2002006352A1 Method for preparing galactomannan oligomers |
| 01/24/2002 | WO2002006351A1 Drugs or cosmetics |
| 01/24/2002 | WO2002006350A1 Polysaccharide crosslinking, hydrogel preparation, resulting polysaccharide(s) and hydrogel(s), uses thereof |
| 01/24/2002 | WO2002006349A1 Gel compositions containing metronidazole |
| 01/24/2002 | WO2002006348A2 Molecular weight reduction of polymer using irradiation treatment |
| 01/24/2002 | WO2002005826A1 Use of polysulphated cyclodextrins for treating osteoarthritis |
| 01/24/2002 | WO2002005783A1 Water soluble microflake through air-gap and process therefore |
| 01/24/2002 | WO2002005753A1 Polymer hydrogel resistant to biodegradation, preparation and use thereof as tissue regeneration support |
| 01/24/2002 | US20020010153 Oral delivery of macromolecules |
| 01/24/2002 | US20020010152 Composition consisting of heparin fractions having reproducible characteristics with average molecular weight equal to 5200d |
| 01/24/2002 | US20020010151 Immuno-active agent, method of its use, and method of immunity activation |
| 01/24/2002 | US20020009782 Heparin and heparan sulfate derived oligosaccharides and a method for their manufacture |
| 01/24/2002 | CA2416698A1 Hydrogel films and methods of making and using therefor |
| 01/23/2002 | EP1174463A1 Hyaluronic acid gel composition, process for producing the same, and medical material containing the same |
| 01/23/2002 | EP1174118A1 Use of inulin and derivatives thereof |
| 01/23/2002 | EP1173601A1 Heteropolysaccharide produced by pseudomonas sp |
| 01/23/2002 | EP1173511A1 Xanthan viscosified compositions and preparation thereof |
| 01/23/2002 | EP1173488A1 Collagen-free cosmetic preparations |
| 01/23/2002 | EP1173451A1 New antioxidative vitamin b 6 analogs |
| 01/23/2002 | EP0888480B1 Cellulosic web with a contaminant barrier or trap |
| 01/23/2002 | CN1332751A Pectin for stabilizing proteins |
| 01/23/2002 | CN1332640A DDS compounds and method for assaying the same |
| 01/23/2002 | CN1332178A Sodium alginate producing process |
| 01/23/2002 | CN1332177A Simple chemical synthesis of hexalentinan glycoside |
| 01/23/2002 | CN1078212C Process for preparing water solutable chitose derivative |
| 01/22/2002 | US6340675 Process for the production of an anticoagulant composition |
| 01/17/2002 | WO2002004471A1 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 01/17/2002 | WO2002004084A2 Process for obtaining bio-functional fractions from biomass |
| 01/17/2002 | WO2002003999A1 High molecular weight polysaccharide fraction from aloe vera with immunostimulatory activity |
| 01/17/2002 | WO2001034091A3 Modification of polysaccharide containing materials |
| 01/17/2002 | WO2001030997A3 Microbe, microbial exopolysaccharide, and uses thereof |
| 01/17/2002 | WO2001030996A3 Microbial exopolysaccharide and uses thereof |
| 01/17/2002 | US20020006991 Pellet of thermoplastic resin dispersed with a cyclodextrin having pendant moieties rendering it compatible with the thermoplastic; cyclodextrin acts as a barrier to trap extractable materials as they permeat through the plastic |
| 01/16/2002 | EP1172386A1 Functionalized glycosaminoglycan polymer and medical instruments and drugs by using the same |
| 01/16/2002 | EP1172368A1 Reduced malto-oligosaccharides |
| 01/16/2002 | EP1171625A1 Purified "alteromonas macleodii" polysaccharide and its uses |
| 01/16/2002 | EP1171473A1 Pectin having reduced calcium sensitivity |
| 01/16/2002 | EP1171234A1 A novel agropolymer used for purification of polluted water or contaminated water containing metal or ions and a method of producing the agropolymer |
| 01/16/2002 | EP1171057A1 Cell-culture and polymer constructs |
| 01/16/2002 | EP0786088B1 Presentation of lipoarabinomannan antigens to t-cells by cd1 molecules |
| 01/16/2002 | EP0742903B1 Piperidine analogs and conjugates of procainamide and napa |
| 01/16/2002 | CN1331703A Substance for reduction of cholesterol as well as lipids content |
| 01/16/2002 | CN1331702A Reduced molecular weight native gellan gum |
| 01/15/2002 | US6339074 Sulfated hyaluronic acid and esters thereof |
| 01/15/2002 | CA2242030C Alginate gel based adsorbents for heavy metal removal |
| 01/15/2002 | CA2191197C Method and means for the production of hyaluronic acid |
| 01/15/2002 | CA2050946C Use of polysaccharides in preparations for wound treatment |
| 01/13/2002 | CA2350434A1 Reduced malto-oligosaccharides |
| 01/10/2002 | WO2002002645A1 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002127A1 Extended type 1 chain glycosphingolipids as tumor-associated antigens |
| 01/10/2002 | WO2001032616A3 Oxetanone derivatives |
| 01/10/2002 | CA2413166A1 Acid-modified arabinogalactan protein composition |
| 01/09/2002 | EP1170592A1 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 01/09/2002 | EP1169387A1 Three-dimensional structures containing hyaluronic acid derivatives obtained by the supercritical antisolvent technique |
| 01/09/2002 | EP1168934A1 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 01/09/2002 | CN1330082A Process for extracting and separating astragalus polyase and astragalus saponin |
| 01/08/2002 | CA2042920C Polydextrose compositions |
| 01/03/2002 | WO2002000188A1 Use of inulin and inulin derivatives |
| 01/03/2002 | WO2002000187A1 Use of inulins and inulin derivatives |
| 01/03/2002 | WO2001066601A8 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 01/03/2002 | WO2000049084A8 Hyaluronic acid gel composition, process for producing the same, and medical material containing the same |
| 01/03/2002 | US20020002243 Biodegradable elastomer, item made of the same and production method of item |
| 01/02/2002 | EP1167435A2 Inclusion compounds of vanillyl alcohol derivative in cyclodextrin and compositions containing the same |
| 01/02/2002 | EP1165684A1 Polymer compositions |
| 01/02/2002 | EP1165621A1 Cyclodextrin polymers and/or cyclodextrin derivatives with complexing properties and ion-exchange properties and method for the production thereof |
| 01/02/2002 | EP1165620A1 INCLUSION COMPLEXES OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES WITH $g(g)-CYCLODEXTRIN |
| 01/02/2002 | EP1165619A1 Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique |
| 01/02/2002 | EP0958307B1 O-sulfated bacterial polysaccharides |
| 01/02/2002 | EP0934342B1 Composition containing chitosan |
| 01/02/2002 | EP0918800B1 Fructan derivatives |
| 01/02/2002 | EP0671414B1 Dermatan sulfate composition as antithrombotic |
| 01/02/2002 | CN1329095A Semi-dry microwave synthesis of carboxymethyl chitosan |
| 01/02/2002 | CN1329094A Extraction and separation method of notoginseng polysaccharide |
| 01/01/2002 | CA2020017C Novel composition and topical and systemic treatments of conditions caused by heavy, oily or greasy secretions |